Spots Global Cancer Trial Database for lymphoma, hodgkin
Every month we try and update this database with for lymphoma, hodgkin cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Precision Exercise in Children With Malignant Hemopathies | NCT04090268 | Leukemia, Myelo... Leukemia, B-cel... Leukemia, T Cel... Lymphoma, Hodgk... Lymphoma, Non-H... Drepanocytosis Thalassemia Maj... Adrenoleukodyst... | Sport Therapy | 2 Years - 18 Years | University of Milano Bicocca | |
| Prospective Cohort Study for Lymphoma: Samsung Lymphoma Cohort Study III | NCT03117036 | Lymphoma, Non-H... Lymphoma, Hodgk... | Chemotherapy | 20 Years - 90 Years | Samsung Medical Center | |
| Early Detection of Patients at Risk of Developing Anthracycline Cardiotoxicity With TEP/CT -FDG | NCT04892667 | Lymphoma, Non-H... Lymphoma, Hodgk... | intervention | 18 Years - | Assistance Publique - Hôpitaux de Paris | |
| Alpha/Beta T Cell and CD19+ B Cell Depletion in Allogeneic Stem Cell Transplantation in Patients With Malignant Diseases | NCT05800210 | Acute Lymphobla... Acute Myeloid L... Juvenile Myelom... Myelodysplastic... Chronic Myeloid... Lymphoma, Non-H... Lymphoma, Hodgk... | Miltenyi CliniM... | 6 Months - 39 Years | University of Florida | |
| A Study of Melphalan in People With Lymphoma Getting an Autologous Hematopoietic Cell Transplant | NCT05540340 | Lymphoma Lymphoma, B-Cel... Lymphoma, T-Cel... Lymphoma, Hodgk... Lymphoma, Non-H... | Pharmacokinetic... | 18 Years - 70 Years | Memorial Sloan Kettering Cancer Center | |
| A Study of Melphalan in People With Lymphoma Getting an Autologous Hematopoietic Cell Transplant | NCT05540340 | Lymphoma Lymphoma, B-Cel... Lymphoma, T-Cel... Lymphoma, Hodgk... Lymphoma, Non-H... | Pharmacokinetic... | 18 Years - 70 Years | Memorial Sloan Kettering Cancer Center | |
| Effect and Safety of Ocoxin Oral Solution on the Quality of Life of Paediatric Patients With Advanced Stage Solid Tumours | NCT06363201 | Advanced Cancer Advanced Solid ... Lymphoma, Hodgk... Central Nervous... Sarcoma Germ Cell Tumor Pediatric Cance... | Ocoxin Oral sol... | 7 Years - 18 Years | Catalysis SL | |
| Early Detection of Patients at Risk of Developing Anthracycline Cardiotoxicity With TEP/CT -FDG | NCT04892667 | Lymphoma, Non-H... Lymphoma, Hodgk... | intervention | 18 Years - | Assistance Publique - Hôpitaux de Paris | |
| Effect and Safety of Ocoxin Oral Solution on the Quality of Life of Paediatric Patients With Advanced Stage Solid Tumours | NCT06363201 | Advanced Cancer Advanced Solid ... Lymphoma, Hodgk... Central Nervous... Sarcoma Germ Cell Tumor Pediatric Cance... | Ocoxin Oral sol... | 7 Years - 18 Years | Catalysis SL | |
| T-Regulatory Cell Kinetics, Stem Cell Transplantation, REGKINE | NCT00578461 | Leukemia Cancer Lymphoma Lymphoma, Hodgk... Lymphoma, Non-H... | Ara C Mesna Cyclophosphamid... TBI-Total Body ... | - 64 Years | Baylor College of Medicine | |
| Effect and Safety of Ocoxin Oral Solution on the Quality of Life of Paediatric Patients With Advanced Stage Solid Tumours | NCT06363201 | Advanced Cancer Advanced Solid ... Lymphoma, Hodgk... Central Nervous... Sarcoma Germ Cell Tumor Pediatric Cance... | Ocoxin Oral sol... | 7 Years - 18 Years | Catalysis SL | |
| Prospective Cohort Study for Lymphoma: Samsung Lymphoma Cohort Study III | NCT03117036 | Lymphoma, Non-H... Lymphoma, Hodgk... | Chemotherapy | 20 Years - 90 Years | Samsung Medical Center | |
| A Study of Brentuximab Vedotin in Participants With Relapsed or Refractory Hodgkin Lymphoma | NCT01990534 | Hodgkin Lymphom... | Brentuximab Ved... | 18 Years - | Takeda | |
| Precision Exercise in Children With Malignant Hemopathies | NCT04090268 | Leukemia, Myelo... Leukemia, B-cel... Leukemia, T Cel... Lymphoma, Hodgk... Lymphoma, Non-H... Drepanocytosis Thalassemia Maj... Adrenoleukodyst... | Sport Therapy | 2 Years - 18 Years | University of Milano Bicocca | |
| Early Detection of Patients at Risk of Developing Anthracycline Cardiotoxicity With TEP/CT -FDG | NCT04892667 | Lymphoma, Non-H... Lymphoma, Hodgk... | intervention | 18 Years - | Assistance Publique - Hôpitaux de Paris | |
| A Study of Melphalan in People With Lymphoma Getting an Autologous Hematopoietic Cell Transplant | NCT05540340 | Lymphoma Lymphoma, B-Cel... Lymphoma, T-Cel... Lymphoma, Hodgk... Lymphoma, Non-H... | Pharmacokinetic... | 18 Years - 70 Years | Memorial Sloan Kettering Cancer Center | |
| T-Regulatory Cell Kinetics, Stem Cell Transplantation, REGKINE | NCT00578461 | Leukemia Cancer Lymphoma Lymphoma, Hodgk... Lymphoma, Non-H... | Ara C Mesna Cyclophosphamid... TBI-Total Body ... | - 64 Years | Baylor College of Medicine | |
| Relevance of a Web-mediated Follow up in Patients Having a Lymphoma With a High Risk of Relapse in Complete or Partial Response | NCT03154710 | Lymphoma, T-Cel... Lymphoma, Large... Lymphoma, Hodgk... | MOOVCARE | 18 Years - | Weprom | |
| Haploidentical BMT With Post-Transplant Cyclophosphamide and Bendamustine | NCT02996773 | Acute Lymphobla... Acute Myelogeno... Myelodysplastic... Chronic Myeloge... Lymphoma,Non-Ho... Lymphoma, Hodgk... Lymphoma, Folli... Marginal Zone L... Large Cell Lymp... Mantle-Cell Lym... Gray Zone Lymph... Burkitt Lymphom... High Risk Undif... | Bendamustine Cyclophosphamid... | 4 Years - 30 Years | University of Arizona |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
